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 The skin offers a protective barrier against allergens, 
irritants, and microorganisms and prevents excessive 
transepidermal water loss (TEWL). The barrier func-
tion strongly relies on the outermost layer of the skin, 
the stratum corneum (SC), which consists of corneocytes 
embedded in a highly organized lipid matrix ( 1, 2 ). This 
lipid matrix is considered to be important for a proper 
skin barrier function. 
 Ceramides (CER), cholesterol, and free fatty acids are 
the main lipid classes in SC. To date, 12 CER subclasses in 
human SC have been identifi ed with a wide chain length 
distribution ( 3, 4 ). An explanation of the CER nomencla-
ture is given in  Fig. 1 .  The aim of the present study was to 
determine the chain lengths of each CER subclass in non-
lesional skin of atopic eczema (AE) patients and to corre-
late these with lipid organization, skin barrier function, 
and disease severity ( Fig. 2 ). 
 AE is a chronic relapsing infl ammatory skin disease 
characterized by a broad spectrum of clinical manifesta-
tions, such as erythema, dryness, and intense pruritus ( 5, 
6 ). AE affects over 15% of Caucasian children and 2–10% 
of adults, and its prevalence is increasing rapidly, especially 
in developed countries ( 7–11 ). Patients have a decreased 
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showed that lesional skin has a signifi cantly increased 
level of short-chain CERs (with a total chain length of 
34 carbon atoms) in one specifi c CER subclass, which 
correlates with the impaired skin barrier function ( 37 ). 
These results suggest that CER chain length may be 
an important factor in skin barrier dysfunction of AE 
patients. These fi ndings were the starting point of the 
present study, in which we performed a detailed analysis 
on CER composition, focusing in particular on the CER 
chain length distribution in nonlesional SC of AE pa-
tients in relation to lipid organization and skin barrier 
dysfunction. We studied SC of nonlesional skin, as we 
aimed to monitor the changes in lipid properties in the 
skin barrier function in lesional and nonlesional skin 
( 12–16 ). 
 In previous studies, it has been shown that AE is strongly 
associated with mutations in the fi laggrin gene ( FLG ) 
( 17–19 ), but the role of  FLG mutations for the barrier dys-
function is yet inconclusive ( 20–25 ). Other factors, such 
as aberrations in the SC lipids, may play a role in the de-
creased skin barrier in AE ( 12, 26, 27 ). In healthy SC, 
lipids form two lamellar phases with repeat distances of 
approximately 6 and 13 nm. These are referred to as 
the short periodicity phase (SPP) and long periodicity 
phase (LPP), respectively ( 28, 29 ). A schematic presen-
tation of the lipid organization is provided in  Fig. 3 . 
 Within the lipid lamellae, the lipids have a dense (or-
thorhombic) lateral organization, although a subpopu-
lation of the lipids can be less densely packed in a 
hexagonal organization ( 30–32 ). 
 CERs play a crucial role in the lipid organization ( 33 ), 
and they have a characteristic molecular architecture. 
Several studies have reported signifi cant changes in 
CER subclasses in nonlesional SC of AE patients: re-
duced CER [NP], increased CER [AS], and reduced 
long chain CERs [EOH] and [EOS] ( 12, 23, 34–36 ). 
Some of these changes could be correlated with changes 
in skin barrier function. However, no information was 
reported on the effect of chain length distribution of 
CERs on the skin barrier until recently. Ishikawa et al. 
 Fig.  1. Structure and nomenclature of CERs. All CERs bear a polar head group and two long carbon chains. The polar head group may 
vary in molecular architecture (at the carbon positions marked in red), resulting in 12 different subclasses in human SC. Both chains in 
every CER subclass show varying carbon chain lengths (marked by red arrows). Each CER subclass is denoted by its sphingoid base (blue) 
and fatty acid chain (gray), resulting in the 12 CER subclasses. Sphingoid base abbreviations: dS, dihydrosphingosine; H, 6-hydroxy sphin-
gosine; P, phytosphingosine; S, sphingosine. Acyl chain abbreviations: A,   -hydroxy fatty acid; EO, esterifi ed   -hydroxy fatty acid; N, non-
hydroxy fatty acid. These abbreviations result in the 12 CER subclasses notations: [NdS], [AdS], [EOdS], [NS], [AS], [EOS], [NP], [AP], 
[EOP], [NH], [AH], [EOH]. The number of total carbon atoms in the CERs (e.g., C34 CERs) is the number of carbon atoms in the fatty 
acid chain plus the number of carbon atoms in the sphingoid base. 
 Fig.  2. Schematic overview of the SC lipid parameters, clinical 
parameters, and the determinants of the fi laggrin content dis-
cussed in this article. These parameters may all affect the skin bar-
rier and are therefore investigated in this study. Arrows indicate 
possible correlations that are discussed. 
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type mutations (see  FLG mutation analysis below). Subjects did 
not apply any dermatological products to their forearms for at 
least one week prior to the study. The study itself was per-
formed in a temperature- and humidity-controlled room, and 
subjects were acclimatized for 45 min prior to the measure-
ments. Per subject, all measurements were performed on a 
single day on one of the ventral forearms, which was observed 
by a dermatologist at the start of the study to carefully depict 
an area of nonlesional skin, which was marked accordingly. 
At this area, NMF levels were determined with Raman spectros-
copy, followed by subsequent tape stripping, TEWL, and Fou-
rier transform infrared spectroscopy (FTIR) measurements, as 
described below. At the end of the study day, buccal mucosa 
cells were collected with a cotton swab, and scoring atopic 
dermatitis (SCORAD) was performed by a dermatologist to de-
termine the severity of the disease. Finally, a 4 mm biopsy was 
harvested close to the area where all measurements were 
performed. 
 FLG mutation analysis 
 The infl uence of  FLG mutations on lipid properties was stud-
ied. We screened all subjects on the four most prevalent muta-
tions found in European Caucasians (2282del4, R501×, S3247×, 
and R2447×), covering around 93% of all  FLG mutations known 
to date ( 38 ). Buccal mucosa cells were collected by rubbing the 
inside of the cheeks with a cotton swab on a plastic stick after rins-
ing the mouth with water. Mutations were determined by geno-
typing after DNA extraction ( 39 ). 
absence of infl ammation. We have identifi ed several 
CER subclasses that exhibit an increased level of extremely 
short C34 chains in AE, and we demonstrate that the over-
all level of C34 is increased in AE. The changes in CER 
chain length distribution correlated with changes in lipid 
organization, skin barrier function, disease severity, and 
levels of natural moisturizing factor (NMF, composed of 
fi laggrin-derived amino acids, their metabolites, specifi c 
sugars, and salts). Changes in CER chain length distri-
bution did not correlate with  FLG genotype. These re-
sults demonstrate for the fi rst time that CER chain 
length is an important factor in skin barrier dysfunction 
in nonlesional skin of AE. 
 MATERIAL AND METHODS 
 Study population and general study setup 
 The study was conducted in accordance with the Declara-
tion of Helsinki and was approved by the Ethical Committee of 
the Leiden University Medical Center. All subjects gave written 
informed consent. Fifteen Caucasian subjects without (history 
of) dermatological disorders (25.0 ± 5.2 years; 5 males) and 28 
Caucasian AE patients (25.6 ± 5.6 years; 11 males) were in-
cluded. The group of AE patients consists of 14 patients with 
and 14 patients without the presence of common  FLG geno-
 Fig.  3. Lamellar and lateral organization in human stratum corneum. (1) The outermost layer of the 
epidermis, the SC, consists of dead cells (corneocytes) embedded in a lipid matrix, also referred to as the 
brick (corneocytes) and mortar (lipids) structure (2). The intercellular lipids are arranged in layers (lamel-
lae) (3), with two coexisting lamellar phases. These lamellar phases have a repeat distance of 6 nm (re-
ferred to as the SPP) or 13 nm (referred to as the LPP). The lateral organization is the plane perpendicular 
to the direction of the lamellar organization. There are three possible arrangements of the lipids: a very 
dense, ordered orthorhombic organization; a less dense, ordered hexagonal organization; and a disordered 
liquid organization. 
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different ratios of solvent mixtures chloroform/methanol/water 
(1:2:1/2; 1:1:0; 2:1:0) were used sequentially to extract all lipids. 
A detailed procedure is described elsewhere ( 45, 46 ). Afterwards, 
lipid extracts from all four individual tapes were pooled, dried 
under N 2 gas, and resolved in 100 µl chloroform/methanol/
heptane (2.5:2.5:95) to obtain a total lipid concentration around 
1.0 mg/ml. Samples were stored at   20°C until use. The analysis 
was performed by LC/MS using a recently developed LC/MS 
method described in detail elsewhere ( 4 ). Briefl y, 10 µl of each 
lipid sample was automatically injected and separated onto an 
analytical normal phase column [PVA-bonded column; 100 × 2.1 
mm id, 5 µm particle size, YMC (Kyoto, Japan)] by a gradient 
solvent system from heptane to heptane/IPA/ethanol at a fl ow 
rate of 0.8 ml/min using an Alliance 2695 HPLC system (Waters, 
Milford, MA). The HPLC was coupled to a mass spectrometer 
(TSQ Quantum, Thermo Finnigan, San Jose, CA) in APCI-positive 
mode with a scan range set at 360–1200 amu. The temperature of 
the source heater and heated capillary were set to 450°C and 
250°C, respectively, and the discharge current was set to 5 µA. 
The ceramide analysis was performed using Xcalibur software 
version 2.0, and its nomenclature used throughout this article is 
according to Motta ( 47 ), in which ceramide subclasses are clas-
sifi ed by letter abbreviations according to their two individual 
chains: the sphingoid base [either dihydrosphingosine (dS), 
sphingosine (S), 6-hydroxy sphingosine (H) or phyto-sphingosine 
(P)] chemically linked to the fatty acid chain [either an   -hydroxy 
fatty acid (A), an esterifi ed   -hydroxy fatty acid (EO), or a non-
hydroxy fatty acid (N)]. This results in 12 different CER sub-
classes, namely, [AdS], [AS], [AH], [AP], [EOdS], [EOS], [EOH], 
[EOP], [NdS], [NS], [NH], and [NP]. The CER nomenclature 
and its molecular structure are explained in  Fig. 1 . 
 Lateral organization and conformational ordering 
of the lipids 
 To obtain information on the lateral organization and con-
formational ordering of the lipids, FTIR spectra were recorded 
in the same skin region also used for lipid analysis. FTIR spectra 
of the SC were collected after each two tape strips using a Var-
ian 670-IR spectrometer (Varian Inc., Santa Clara, CA) equipped 
with a broad band Mercury-Cadmium-Telluride (MCT) detec-
tor and an external sample compartment containing a Gladi -
ATR (Pike, Madison, WI) attenuated total refl ection (ATR) 
accessory with a single-refl ection diamond. The spectral resolu-
tion was 2 cm   1 . The instrument was continuously purged with 
dry N 2 . Each spectrum was an average of 150 scans. For data 
treatment, the instrument software Resolutions Pro 4.1 (Varian 
Inc.) was used. We calculated positions of the CH 2 symmetric 
stretching vibration and second derivatives of the scissoring 
bandwidth as described previously ( 48, 49 ). Shortly, the second 
derivative was calculated, and it was baseline corrected between 
the endpoints of the scissoring region (  1,460–1,480 cm   1 ). 
We calculated the bandwidth at 50% of the peak height (full 
width half maximum, FWHM) and determined CH 2 symmetric 
stretching vibration positions of spectra recorded between the 
removal of 2–10 tape strips. 
 Biopsy and small angle X-ray diffraction measurements 
 After tape stripping, 4 mm biopsies were taken from the 
ventral forearm close to the region of the tape stripping. SC 
was isolated by trypsin digestion as described earlier ( 50 ). This 
procedure does not affect the lipid organization in SC ( 51 ). 
The SC sheets were measured by small angle X-ray diffraction 
(SAXD) performed at the European Synchrotron Radiation 
Facility (ESRF, Grenoble, France) using station BM26B. Prior 
to the measurements, SC was hydrated over a 27% NaBr solution 
 Skin barrier function assessment by TEWL 
 A Tewameter TM 210 (Courage+Khazaka, Köln, Germany) 
was used to measure TEWL on the marked area on the ventral 
forearm of the subject. The forearm was placed in an open cham-
ber, and TEWL values were recorded for 2 min, after which an 
average reading during the last 10 s of the measurement was cal-
culated. This procedure was performed before tape stripping 
(baseline TEWL) and after every two tape strips to have an indi-
cation of the amount of removed SC. 
 SCORAD 
 SCORAD was performed by the dermatologist to determine 
the severity of the disease ( 40 ). 
 Determination of NMF levels in SC 
 Confocal Raman microspectroscopy (3510 Skin Composition 
Analyzer, River Diagnostics, Rotterdam, The Netherlands) was 
used to measure NMF in the SC of the ventral forearm. The prin-
ciples and experimental details of this method and the proce-
dure have been described elsewhere ( 41, 42 ). Depth profi les of 
Raman spectra were measured at 2 µm intervals from the skin 
surface to 20 µm below the skin surface. In each subject, 15 pro-
fi les were measured at different spots within the marked area on 
the ventral forearm. Raman spectra were recorded between 400 
and 1,800 cm   1 with a 785 nm laser. Laser power on the skin was 
25 mW. NMF levels relative to keratin were determined from the 
Raman spectra measured between 4 and 8 µm by means of classi-
cal least-squares fi tting. Relative NMF to keratin levels were calcu-
lated from the recorded Raman spectra by using SkinTools 2.0 
(River Diagnostics). 
 Tape stripping procedure 
 To harvest SC lipids, the following tape stripping procedure 
was performed on both control subjects and nonlesional regions 
of AE patients: multiple poly(phenylene sulfi de) tape strips 
(Nichiban, Tokyo, Japan) were successively applied at the same 
area (4.5 cm 2 ) on the ventral forearm. All tapes were pressed to 
the targeted skin with a pressure of 450 g/cm 2 using a D-Squame 
pressure instrument (Cuderm Corp., Dallas, TX). Tweezers were 
used to remove the tape in a fl uent stroke, using alternating di-
rections for each successive tape strip. The Squamescan 850A 
(Heiland Electronic, Wetzlar, Germany) was used to determine 
the amount of SC removed to obtain a good indication of the 
depth of each tape strip taken ( 43, 44 ). Calibration was per-
formed by a bicinchoninic acid (BCA) assay using BSA. The pre-
dicted total amount of protein in the SC was calculated by plotting 
1/TEWL against the cumulative amount of protein removed. 
The intercept with the  x axis is indicative for the total amount of 
protein in the SC according to Kalia ( 43 ). Tapes 6–9 were se-
lected for lipid composition analysis, as these tapes do not show 
surface contamination (observed when analyzing tape strips from 
the surface of the SC). All tapes were punched to a circular area 
of 2 cm 2 , put individually into glass vials containing 1 ml chloro-
form/methanol/water (1:2:1/2) and stored at   20°C under ar-
gon atmosphere prior to lipid extraction. 
 Lipid extraction and ceramide analysis by LC/MS 
 Lipid extraction was performed on four tape strips (numbers 
6–9) of each subject. Before lipids were extracted from tape strips 
by liquid-liquid extraction, two deuterated internal ceramide 
standards (CER [NS] C24 and, CER [EOS] C30 linoleate) were 
added to compare CER levels between control group and nonle-
sional skin of AE patients. Then, a slightly enhanced extraction 
procedure of the commonly used Bligh and Dyer method was 
performed on all four selected tape strips individually: three 
 at W
alaeus Library / B
IN











Supplemental Material can be found at:
Barrier dysfunction in atopic eczema 2759
 Reduced CER chain length correlates with a decreased 
barrier function 
 From the LC/MS data, lipid profi les were constructed, 
and examples are shown in supplementary Fig. I. From 
manual integration of these lipid profi les, the relative 
abundance of all CER subclasses could be calculated 
(supplementary Fig. II). Statistical differences between 
control subjects and AE patients were observed in seven 
subclasses: CERs [EOP], [EOH], [NS], [NP], [NH], [AS], 
and [AH] ( P  < 0.05). No difference was observed between 
carriers and noncarriers of  FLG mutations. The total CER 
level in the control group and in nonlesional skin of AE 
patients was not signifi cantly different (37.0 ± 3.6 and 
38.5.4 ± 2.4 ng/  g protein, respectively;  P  > 0.1). 
 The average CER chain length was signifi cantly de-
creased by 0.64 ± 0.23 total carbon atoms in AE patients 
(mean ± SEM;  P  = 0.012) ( Fig. 5A ).  No difference was 
observed between carriers and noncarriers of  FLG mu-
tations ( P  > 0.1).  Fig. 5A shows that in nonlesional skin 
of AE patients, extremely short C34 CERs were increased 
within several CER subclasses. This was primarily observed 
in CER subclasses [AS], [AH], [NS], and [NH] ( P  < 0.05) 
( Fig. 5B ). The increase in total C34 CERs in AE ( P < 
0.0001) contributes to a reduction in overall chain 
length. In addition, the very long chain CERs belonging 
to the [EO] subclass are signifi cantly reduced, which is 
primarily caused by signifi cantly decreased levels of CER 
[EOH] and [EOP] ( P  = 0.019 and  P  = 0.040, respec-
tively) ( Fig. 5A and supplementary Fig. II-B). Univariate 
analysis shows that an increased level of C34 CERs and 
decreased level of CERs [EO] largely contribute to a re-
duction in average CER chain length, as can be observed 
from  Fig. 5C . The infl uence of  FLG mutations on any 
of the CER chain length parameters was not signifi cant 
( P > 0.1) (detailed overview in supplementary Tables 
III–V). 
 The observed changes in CER chain length were com-
pared with changes in barrier function as assessed by 
TEWL. The results in  Fig. 5D show a strong correlation 
during 24 h. To obtain high-quality diffraction patterns, SC 
was carefully oriented parallel to the primary X-ray beam. 
SAXD patterns were detected with a Frelon 2000 CCD detec-
tor at room temperature for a period of 10 min using a micro-
focus beam, similarly as described elsewhere ( 52 ). Samples 
were checked for evidence of radiation damage, and exposure 
time to X-rays was kept to a minimum. From the scattering 
angle, the scattering vector ( q ) was calculated by  q = 4  sin 
  /  , in which   is the wavelength of the X-rays at the sample 
position and   the scattering angle. 
 Statistical analysis 
 Statistical analysis was performed using SPSS Statistics. Non-
parametric Mann-Whitney tests were performed when compar-
ing two groups and stated signifi cant when  P  < 0.05. When the 
effect of  FLG was taken into account and trends were observed, 
Kruskall-Wallis tests and, eventually, an additional Mann-Whitney 
test was performed. Bivariate analysis was performed to analyze 
which parameters showed a signifi cant correlation, and their re-
spective Spearman’s  	 correlation coeffi cients were calculated. 
Univariate general linear model analysis was performed to cor-
relate the biologically and clinically relevant parameters to two 
independent lipid parameters, as well as to the predicted and the 
observed average chain length. 
 RESULTS 
 Description of study population 
 Fourteen out of 28 AE patients were carriers of at least 
one of the four most common  FLG mutations (details in 
supplementary Table I). Patient and control subject char-
acteristics are provided in supplementary Table II. Two 
control subjects were heterozygous for  FLG mutations. Se-
verity of the disease was scored by an experienced derma-
tologist using SCORAD ( Fig. 4A ).  AE patients showed an 
elevated TEWL in nonlesional skin compared with control 
subjects (12.2 ± 6.5 g/m 2 /h and 6.5 ± 1.7 g/m 2 /h, respec-
tively;  P  < 0.0005) ( Fig. 4B ) and lower NMF levels com-
pared with control subjects (0.66 ± 0.39 and 1.05 ± 0.20, 
respectively;  P < 0.01) ( Fig. 4C ). 
 Fig.  4. SCORAD, TEWL, and NMF levels in control subjects and AE patients. Dot plots showing individual 
control subjects (open and fi lled circles) and AE patients (open and fi lled diamonds) of the measured pa-
rameters (A) SCORAD, (B) TEWL, and (C) NMF levels. Open and fi lled data points indicate carriers and 
noncarriers of  FLG mutations, respectively. Means are indicated by gray horizontal lines and their corre-
sponding values (± SD). Signifi cant differences were observed between control subjects and AE patients for 
both TEWL and NMF.  FLG mutations were associated with reduced NMF levels in AE patients ( P  < 0.005) but 
not with SCORAD and TEWL. 
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 Fig.  5. CER composition in control subjects and AE patients. (A) Dot plot showing the average chain length of all CERs in total; the rela-
tive abundance of total C34 CERs, and the relative abundance of total [EO] CERs. (B) Dot plots indicating the relative abundance of C34 
CER species for each subclass. (C) Scatter plot of univariate analysis of the predicted average chain length (by the abundance of C34 CERs 
and [EO] CERs) versus the observed average chain length. Gray dotted line represents the optimal fi t ( r = 0.94): Average chain length = 
(0.33 × C34 CERs) + (0.24 × CER[EO]). (D) Scatter plot of univariate analysis of C34 CER and CER [EO] versus the TEWL. Insets show the 
residuals of the respective plots. Gray dotted line represents the optimal fi t ( r = 0.77): TEWL = 8.2 + (4.6 × C34 CERs)   (0.6 × CER[EO]). 
Control subjects are indicated by open and fi lled circles. AE patients with are indicated by open and fi lled diamonds. Data points indicate 
carriers and noncarriers of  FLG mutations, respectively. 
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control subjects. The average position of the strong peak 
is located at signifi cantly higher q-values for AE patients 
compared with control subjects (1.03 nm   1 and 1.00 nm   1 , 
respectively;  P  = 0.046). The position of peak II showed no 
difference between AE patients with and patients without 
 FLG mutations ( P  = 0.76). 
 FTIR was used to obtain information on the lateral 
lipid organization. Two types of vibrations were moni-
tored, the CH 2 symmetric stretching vibrations and the 
CH 2 scissoring vibrations (supplementary Fig. IV). A 
low (  2,848 cm   1 ) wave number of the CH 2 symmetric 
stretching vibrations indicates the presence of a highly 
ordered lipid organization (either hexagonal or ortho-
rhombic), whereas a high (2,853 cm   1 ) wave number in-
dicates a liquid disordered phase ( 53 ). The mean value 
of the position of the CH 2 symmetric stretching vibra-
tions of AE patients shows a small but signifi cant shift to 
higher values compared with control subjects (2,849.2 
cm   1 versus 2,848.8 cm   1 , respectively;  P  = 0.0013) ( Fig. 
6C ). In addition, the variance in the group of AE patients 
is larger than in control subjects. To distinguish between 
an orthorhombic (dense) or hexagonal (less dense) lat-
eral organization, the bandwidth of the CH 2 scissoring 
vibrations was monitored. A narrow bandwidth (typically 
8 cm   1 ) indicates the presence of only a hexagonal lipid 
organization, whereas a large bandwidth of typically 
11 cm   1 is indicative for the presence of mainly an or-
thorhombic organization ( 49 ). The average bandwidth 
of the scissoring vibrations was signifi cantly lower in AE 
patients compared with control subjects (10.6 cm   1 ver-
sus 11.6 cm   1 , respectively;  P  = 0.010) ( Fig. 6D ), demon-
strating a reduction of lipids in an orthorhombic orga-
nization and thus a less dense lipid organization. No 
signifi cant infl uence of  FLG mutations on the lipid or-
ganization in AE patients was found ( P  > 0.05) ( Fig. 
6B–D ). 
 Univariate analysis was performed between TEWL and 
two independent lipid organization parameters: a lamellar 
organization component (SAXD peak II position) and a 
lateral organization component (FTIR scissoring band-
width). The correlation coeffi cient was  r = 0.76 ( P  < 0.0001) 
( Fig. 6E ), which demonstrates that skin barrier function as 
measured by TEWL is signifi cantly infl uenced by lipid 
organization. 
 Altered CER composition correlates with aberrant 
lipid organization 
 As CER composition and lipid organization both show a 
relationship with a reduced skin barrier (TEWL), the rela-
tion between the lipid parameters is summarized in  Table 2 . 
 The levels of C34 CERs and CER [EO] associate with 
both the lamellar organization (SAXD) and lateral lipid 
organization (FTIR scissoring bandwidth and stretching 
vibrations position). A powerful correlation of 0.71 was ob-
served when both the lamellar and lateral organization 
components (SAXD and CH 2 scissoring) were plotted 
versus the two components of the CER composition 
([EO] CERs and C34 CERs). Supplementary Fig. V illus-
trates this correlation. 
between TEWL and the levels of C34 CERs and CER [EO]: 
univariate analysis of TEWL versus the total C34 CERs and 
total CER [EO] levels shows a correlation coeffi cient of 
0.77 ( P  < 0.0001). 
 Correlations between the relative abundances of the 
various CER subclasses with TEWL are shown in  Table 1 . 
 CER [EOH] and CER [AS] are the two subclasses that are 
most signifi cantly associated with TEWL. This again indi-
cates the importance of the chain length for the skin bar-
rier in AE: the exceptionally long CER [EOH] is decreased, 
whereas CER [AS], the CER subclass with the highest 
abundance of exceptionally short C34 CERs, is increased. 
The changes in CER composition are irrespective of  FLG 
mutation status ( P  = 0.58). 
 Altered lamellar and lateral lipid organization correlates 
with a decreased barrier function 
 SAXD gives information about the lamellar organiza-
tion of intercellular lipids in SC ( 28 ) (explanation in 
supplementary Fig. III). The lipids form two lamellar 
phases, the SPP and LPP.  Fig. 6A  shows three examples 
of SAXD curves of SC. The upper curve is a typical 
example from a control subject. The central curve is 
typical for AE. The bottom curve is representative for a 
subgroup of AE patients with an aberrant SAXD profi le. 
The upper two curves show lipid-based features as two 
weak diffraction peaks (labeled I and III) and a strong 
peak (labeled II). The LPP contributes to all three 
peaks, whereas the SPP contributes only to peak II (sup-
plementary Fig. III). In the bottom curve, both peaks I 
and III are absent, and peak II is shifted to higher q-
values. Peaks I and III were not present in 5 out of 28 
patients. As peak I and peak III are attributed only to 
the LPP, this indicates that there is a drastic reduction 
in the presence of the LPP in those patients. 
 Fig. 6B shows the position of the strong peak (II) in the 
SAXD curves from control subjects (left) and AE patients 
(right). The peak position shows a larger variance within 
the group of AE patients compared with the group of 
 TABLE 1. Correlation coeffi cients of CER subclasses versus TEWL 
CER Subclass TEWL
CER [EOdS]   0.245
CER [EOS]   0.177
CER [EOP]   0.434**
CER [EOH]   0.617***
CER [NdS]   0.226
CER [NS] 0.407**
CER [NP]   0.483**





Total CER [EO]   0.441**
Total C34 CERs 0.738***
Average CER chain length   0.528***
The table contains all 12 CER subclasses as well as the CER that 
strongly infl uence the chain length (i.e., total CER [EO] and total 
C34 CER).
 **P  < 0.01.
*** P < 0.001.
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 FLG mutations correlate with NMF levels, but not with 
SCORAD and TEWL levels 
 NMF levels were signifi cantly lower in  FLG carriers than 
in noncarriers (0.45 ± 0.19 and 0.87 ± 0.43, respectively;  P  < 
0.005). Both SCORAD and TEWL values were independent 
of  FLG genotype ( P  = 0.34 and  P  = 0.23. respectively). 
 DISCUSSION 
 We performed an integral analysis of CER composition 
focusing on the chain length distribution of each of the 
CER subclasses in relation to lipid organization and their 
 Altered CER composition and aberrant lipid organization 
correlate with NMF levels and SCORAD 
 A detailed overview of correlation coeffi cients be-
tween different parameters is presented in  Table 3 .  NMF 
levels correlate ( r > 0.4;  P  < 0.01) with both lamellar and 
lateral lipid organization as well as with chain length of 
the CERs. SCORAD (disease severity) was associated 
with CER composition (i.e., total C34 CERs and total 
CER [EO] content) and lipid organization (i.e., SAXD 
peak II position and FTIR scissoring bandwidth), with 
correlation coeffi cients of 0.56 ( P  < 0.01) and 0.58 ( P  < 
0.01), respectively. 
 Fig.  6. Lipid organization in control subjects and AE patients. (A) The upper SAXD curve of a control subject shows the fi rst (I), second 
(II), and third (III) order peak positions of the LPP.  # Phase-separated cholesterol. The middle diffraction curve is from an AE patient and 
resembles the pattern of SC of the control subject. The bottom curve of an AE patient shows only the presence of peak II. (B) Position of 
peak II in SAXD curves. (C) Position of the stretching vibrations in the FTIR spectrum. (D) Scissoring bandwidth in the FTIR spectrum. 
(E) Correlation between lipid organization and TEWL. Scatter plot of univariate analysis of SAXD peak II position + bandwidth of scissor-
ing vibrations versus the TEWL. The inset shows the residuals of this plot. The gray dotted line represents the optimal fi t ( r = 0.76): TEWL = 
  30.1 + (64 × SAXD peakII position)   (2.3 × Bandwidth). The correlation coeffi cient is 0.76. Control subjects are indicated by open and 
fi lled circles AE patients with are indicated by open and fi lled diamonds. Data points indicate carriers and noncarriers of  FLG mutations, 
respectively. 
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In addition, the results show changed levels in some of the 
CER subclasses consistent with previous reports: a decrease 
in CER [NP] level and an increase in CER [AS] level ( 12, 
34–37, 54, 55 ). We did not observe a change in CER/pro-
tein levels between AE patients and controls. Interestingly, 
the reduction in CER chain length found in the present 
study had a much stronger impact on the skin barrier 
function than did the changes in CER subclass levels: the 
TEWL increases proportionally with decreasing chain 
length. These fi ndings are in excellent agreement with 
earlier in vitro studies showing that a reduction in chain 
length of CERs has a stronger impact on the lipid organi-
zation and permeability than a change in the ratio between 
CER subclasses keeping the chain length approximately 
equal (Refs  56–58 ; M. Oguri, G. S. Gooris, and J. A. Bouwstra, 
unpublished data). 
 Di Nardo et al. observed a reduction in CER/CHOL 
ratio in nonlesional skin of AE patients, whereas other 
studies do not report a decrease in CER content in nonle-
sional AE skin ( 20, 35–37, 54 ). Groen et al. ( 58 ) observed 
that increasing the CER or FFA level while keeping the 
level of the other two main lipid classes equal did not af-
fect the permeability in vitro. These studies suggest that 
the CER composition and chain length rather than the 
ratio between lipid classes play a major role in the in-
creased TEWL in nonlesional skin in patients with AE. 
The increment in C34 CERs and decrement in CER [EO] 
suggest that elongation of the acyl chains is reduced. As 
the elongase family plays an important role in the elonga-
tion of fatty acids in the viable epidermis, we hypothesize 
that the higher abundance of C34 CERs may be due to a 
misbalance in the activity of some of the members of the 
elongase family ( 59, 60 ). 
 Several publications report on the lipid organization in 
AE patients: Pilgram et al. reported changes in lateral 
packing when comparing three AE patients with three 
controls ( 32 ). In a very recent study, we reported the fi rst 
results on a very limited number of subjects, focusing on 
the lamellar phases and ceramide subclasses without ex-
amining the CER chain lengths ( 61 ). In addition, several 
studies focused on the (delayed or incomplete) lamellar 
body extrusion process in AE ( 62–64 ), possibly caused by 
reduced peroxisome proliferator-activated receptor activa-
tion ( 65 ). In the present study, we were particularly inter-
ested in the infl uence of CER chain length on the lipid 
organization in AE patients. 
 With respect to the lamellar lipid organization, we ob-
served a shift in peak II position of the SAXD curves of SC 
of AE patients. This observation indicates a reduced value 
of the repeat distances of the lamellar phases and/or a 
reduced formation of the LPP ( 28 ). The correlation be-
tween SAXD peak II position with CER [EO] and C34 CER 
levels indicates that changes in these CER levels affect the 
lamellar organization. When focusing on the lateral orga-
nization, AE patients show a less dense lipid packing com-
pared with controls that correlates strongly with a higher 
level of C34 CERs. This fi nding shows that CER chain 
length is also an important determinant of the lateral lipid 
organization in SC. The observed changes in lamellar and 
correlation with skin barrier function (TEWL), disease 
severity (SCORAD),  FLG mutations, and NMF levels. This 
study provides detailed information about the role of lip-
ids in the impaired skin barrier function of nonlesional 
AE skin. 
 The results show a reduced average CER chain length in 
nonlesional skin of AE patients. This reduction in chain 
length can be attributed to an increase in extremely short 
C34 CERs as well as a reduction in very long CER [EO] 
subclasses. The increment in C34 CERs has recently been 
reported by Ishikawa et al. for a single subclass (CER [NS]) 
in lesional skin of AE patients ( 37 ). Here we show in non-
lesional skin a largely increased level of C34 CERs in 
four CER subclasses: CER [NS], [NH], [AS], and [AH]. 
 TABLE 2. Correlation coeffi cients of lipid composition and lipid 
organization parameters 
Lipid Organization / CER Composition Parameter Correlation Coeffi cient ( r )
SAXD peak II position versus total C34 CER 
content
0.432**
SAXD peak II position versus total CER [EO] 
content
  0.393**
SAXD peak II position versus average CER 
chain length
  0.370*
FTIR scissoring bandwidth versus total C34 
CER content
  0.669***
FTIR scissoring bandwidth versus total CER 
[EO] content
0.267
FTIR scissoring bandwidth versus average CER 
chain length
0.386*
FTIR stretching versus total C34 CER content 0.607***
FTIR stretching versus total CER [EO] content   0.399*
FTIR stretching versus average CER chain 
length
  0.471**
* P  < 0.05.
** P  < 0.01.
*** P  < 0.001.
 TABLE 3. Correlations between parameters 
Correlated Parameters Correlation Coeffi cient ( r )
TEWL versus SCORAD 0.560**
TEWL versus SAXD peak II position 0.450**
TEWL versus FTIR scissoring bandwidth   0.735**
TEWL versus FTIR stretching 0.645**
TEWL versus total C34 CER content 0.738**
TEWL versus total CER [EO] content   0.441**
TEWL versus average CER chain length   0.528**
TEWL versus NMF   0.643**
SCORAD versus SAXD peak II position 0.164
SCORAD versus FTIR scissoring bandwidth   0.474*
SCORAD versus FTIR stretching 0.534**
SCORAD versus total C34 CER content   0.470*
SCORAD versus total CER [EO] content   0.238
SCORAD versus average CER chain length   0.265
SCORAD versus NMF   0.362*
NMF versus SAXD peak II position   0.501**
NMF versus FTIR scissoring bandwidth 0.697**
NMF versus FTIR stretching   0.778**
NMF versus total C34 CER content   0.611**
NMF versus total CER [EO] content 0.416**
NMF versus average CER chain length 0.456**
The SCORAD indicates the severity of AE and gives valid values 
only when AE is diagnosed. Therefore, all control subjects were 
excluded in these specifi c correlations.
*Correlation is signifi cant at the 0.05 level.
**Correlation is signifi cant at the 0.01 level.
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lateral organization correlate with the increased TEWL 
levels and thus with an abnormal skin barrier function in 
patients with AE. The fi ndings in this study strongly sup-
port the hypothesis that, in AE patients, a reduction in 
CER chain length leads to a change in lipid organization, 
which in turn leads to an impaired barrier function. In ad-
dition, the present study shows that this impaired barrier 
function is correlated with disease severity as determined 
by SCORAD, which is supported by literature ( 66, 67 ). 
This may indicate that, as a result of infl ammation, lipid 
synthesis is infl uenced (even at nonlesional sites), and sub-
sequently, the barrier function is decreased. 
 As  FLG mutations are known to be predisposing factors 
for AE ( 17 ), an interesting question is whether lipid changes 
are associated with the presence of  FLG mutations. We 
screened our subjects for four of the most prevalent  FLG 
mutations accounting for 93% of the European  FLG muta-
tion spectrum ( 38 ). In our study cohort, there is no evi-
dence that  FLG mutations have an effect on CER composition 
and lipid organization. In contrast, in a recent study in ich-
tyosis vulgaris patients ( 68 ), changes in the lamellar organi-
zation were observed between the patients and controls. In 
that investigation, however, the majority of the patients were 
homozygote or compound heterozygote with respect to 
 FLG mutations, and no infl ammation was observed in these 
patients. 
 In previous studies, as well as in the current study, AE 
patients with  FLG mutations showed signifi cantly reduced 
NMF levels ( 22, 69 ). Remarkably, in this study, changes in 
lipids correlated with NMF levels but not with the pres-
ence or absence of  FLG mutations. This suggests that be-
tween  FLG gene (genotype) and NMF (phenotype), other 
(translational and environmental) factors may also infl u-
ence NMF levels. These factors may include  FLG copy 
numbers (repeat alleles on the  FLG gene) ( 70 ) and inter-
leukin levels, which can downregulate fi laggrin expression 
( 71 ). Changes in NMF levels are suggested to lead to a 
change in pH, and together with altered interleukin levels 
and protease activity, this may affect enzymes involved in 
CER biosynthesis ( 5, 68, 72–74 ) and, therefore, change the 
CER composition and lipid organization. Thus, despite the 
fact that we did not fi nd a correlation between the lipids 
and  FLG mutation status, fi laggrin might play an indirect 
role in the decreased barrier function of AE patients, al-
though the underlying mechanism remains unclear. Be-
sides, other barrier proteins may be involved. This will be 
subject of future studies by our group. 
 In conclusion, in this study, we have shown that the CER 
chain length is altered in AE patients by elevated C34 CER 
levels and reduced CER [EO] levels. These changes cor-
relate with an altered lipid organization and a decreased 
barrier function in AE patients. In addition, a signifi cant 
correlation was observed between disease severity and 
change in lipid composition and organization. Our results 
suggest a novel therapeutic entry to repair skin barrier 
defects in AE patients, aimed at normalizing CER chain 
length distribution. Such a treatment could improve the 
SC lipid organization and restore the skin barrier function 
of AE patients.  
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